In vitro studies on the impact of human serum on the antibacterial effect of faropenem

Journal of Chemotherapy

Volumn 16, Issue 1, 2004, Pages 23-29

  MacGowan, A ^a   Bowker, K ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Antibacterial effect; Faropenem; Protein binding

Indexed keywords

FROPENEM;

ANTIBACTERIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; CALCULATION; CONCENTRATION RESPONSE; DRUG ACTIVITY; DRUG PROTEIN BINDING; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; SERUM; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 1942423093     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2004.16.1.23     Document Type: Article

References (12)

1. Boswell FJ, Ashby JP, Andrews JM, Wise R. Effect of protein binding on the in vitro activity and pharmacodynamics of faropenem. Antimicrob Chemother 2002; 50: 525-532.
2. st Interscience Conference on Antimicrobial Agents and Chemotherapy, 2001, Chicago, Abstract A-2094, p34.
3. Andes D, Craig WA. In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae: application to breakpoint determinations. Antimicrob Agents Chemother 1998; 42: 2375-2379.
4. Lovering AM, White LO, Lewis DA, MacGowan AP, Routh KR, Pickin DM, Reeves DS. Pharmacokinetics of FCE 22101 in man following different modes of administration. Antimicrob Chemother 1989; 23, Supplement C: 179-196.
5. Fuhst C, Barger A, Wiegand I, Wiedeman B. The impact of protein binding of faropenem on its antibiotic activity. Clin Microbiol Infect 2002; 8, Supplement 1: Abstract P-1395, p328.
6. National Committee for Clinical Laboratory Standards (2000) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard 5th Edition M7-A5, Wayne, PA, USA.
7. th Interscience Conference on Antimicrobial Agents and Chemotherapy 2000; Ontario. Abstract 365, p160.
8. th Interscience Conference on Antimicrobial Agents and Chemotherapy, 2000; Ontario. Abstract 361, p159.
9. st Interscience Conference on Antimicrobial Agents and Chemotherapy 2001; Chicago, E-798, p184.
10. st Interscience Conference on Antimicrobial Agents and Chemotherapy 2001; Abstract 2078, p30.
11. th Interscience Conference on Antimicrobial Agents and Chemotherapy. 2000; Abstract 498, p159.
12. Gustafsson I, Cars O. The influence of protein binding on the effect of faropenem against H. influenzae, Clin Microbiol Infect 2002; 8, Supplement 1: Abstract P1390, p326.